On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic. As COVID-19 has spread around the globe, Lenco Diagnostic Laboratories has diligently focused its efforts on expanding high quality testing to help be part of the solution for New York- one of the continuously hardest hit areas throughout this public health crisis.
Lenco Diagnostic Laboratories offer high-throughput, automated testing that utilizes RT-PCR (Real-Time Polymerase Chain Reaction) diagnostic testing to provide a molecular-based assay for the qualitative detection of the SARS-COV-2 virus. It is performed using only respiratory specimens of patients who meet COVID-19 clinical and/or epidemiological criteria for testing. Specimens (swabs) for the COVID-19 test should only be collected by authorized healthcare providers.
Lenco Patient Service Centers DO NOT collect RT-PCR specimens (swabs) from patients. Patients who have been exposed to COVID-19 or develop symptoms should consult their physician or healthcare provider. Please refer to CDC guidelines for the most up to date information.
COVID-19 RT-PCR testing is covered by most insurances. The self-pay price for testing is $100.
For more information on Lenco Diagnostic Laboratories COVID-19 Antibody Test.
Lenco is a full-service clinical reference laboratory offering clinical diagnostics at its best. The laboratory is renowned for excellence and expertise with Lenco’s highly dedicated team of specialists in the field who possess experience, professionalism and dedication. Lenco continuously meets the needs of their physician clients and their patients and is committed to being one of the top leading laboratories in a world of rapidly advancing diagnostic technology. To learn more about Lenco, visit www.lencolab.com.
Note: Please contact your referring physician for any questions about your test results. To view your test results, click here.